Focusing on the

Enteric Nervous System

Millions of patients suffer from gastrointestinal disorders that are poorly treated

At Neurogastrx we believe we can change that

illustration Neurogastrx

Neurogastrx, Inc. is a venture-stage biopharmaceutical company developing products for the treatment of gastrointestinal disorders.

The enteric nervous system contains more neurons than the spinal cord, hosts 90% of the body’s serotonin and 50% of the body’s dopamine.

Responsible for the control of gastrointestinal tract's movement, function and sensations, it represents an attractive target for the treatment of many gastrointestinal disorders.